Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle
S Miyake1, W R Sellers, M Safran
1Department of Adult Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract:
Control of proliferation and differentiation by the retinoblastoma tumor suppressor protein (pRB) and related family members depends upon their interactions with key cellular substrates. Efforts to identify such cellular targets led to the isolation of a novel protein, EID-1 (for E1A-like inhibitor of differentiation 1). Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity. EID-1 is rapidly degraded by the proteasome as cells exit the cell cycle. Ubiquitination of EID-1 requires an intact C-terminal region that is also necessary for stable binding to p300 and pRB, two proteins that bind to the ubiquitin ligase MDM2. A pRB variant that can bind to EID1, but not MDM2, stabilizes EID-1 in cells. Thus, EID-1 may act at a nodal point that couples cell cycle exit to the transcriptional activation of genes required for differentiation.
Insights
EID-1 protein inhibits cell differentiation by blocking p300/CBP histone acetylation. Its degradation is linked to cell cycle exit, revealing a novel mechanism coupling differentiation to cell cycle control.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The retinoblastoma tumor suppressor protein (pRB) controls cell proliferation and differentiation through substrate interactions.
- Identifying cellular targets of pRB is crucial for understanding these processes.
Purpose of the Study:
- To identify novel cellular substrates involved in pRB-mediated cell cycle control.
- To investigate the role of EID-1 (E1A-like inhibitor of differentiation 1) in cell differentiation and its relationship with pRB and p300/CBP.
Main Methods:
- Protein isolation and identification (EID-1).
- Assays to measure EID-1's effect on p300/CBP histone acetylation activity.
- Studies on EID-1 degradation via the proteasome.
- Analysis of EID-1 ubiquitination and its interaction with p300, pRB, and MDM2.
Main Results:
- EID-1 was identified as a novel protein and a potent inhibitor of cell differentiation.
- EID-1 inhibits the histone acetylation activity of p300 and CREB-binding protein (CBP).
- EID-1 undergoes rapid proteasomal degradation upon cell cycle exit, requiring its C-terminal region for binding to p300/pRB and ubiquitination by MDM2.
Conclusions:
- EID-1 acts as a key regulator linking cell cycle exit to the transcriptional activation of differentiation genes.
- The interaction and degradation of EID-1 involving pRB, p300/CBP, and MDM2 represent a novel regulatory pathway in cell differentiation.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Inhibition of CDK Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...


